Segara et al. (32) found that the level of IFITM1 in pancreatic cancer was significantly increased compared to adjacent normal pancreas samples, with a fold change of 5.521 and a p-value of 6.78E-7. Here, IFITM1 is linked to pancreatic neoplasm.